Lexeo Therapeutics (LXEO) Shares Issued (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Shares Issued of $52285.0 for Q1 2026, down 19.98% on a YoY basis from $65342.0 in Q1 2025, and down 98.81% sequentially from $4.4 million in Q4 2025.
Lexeo Therapeutics (LXEO) Shares Issued (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Shares Issued data on file, last reported at $52285.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 19.98% year-over-year to $52285.0; the trailing twelve-month figure through Mar 2026 stood at $52285.0 (down 19.98% YoY), and the FY2025 full-year result was $4.4 million, up 27.15% from the prior year.
- Shares Issued fell to $52285.0 in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $4.5 million in Q3 2025 to a low of $52285.0 in Q1 2026.
- A 5-year average of $2.8 million and a median of $3.4 million in 2024 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued soared 49.47% in 2024 and tumbled 98.03% in 2025, its largest moves.
- Tracing LXEO's Shares Issued over 5 years: stood at $1.9 million in 2022, then rose by 26.07% to $2.4 million in 2023, then jumped by 43.14% to $3.5 million in 2024, then climbed by 27.15% to $4.4 million in 2025, then plunged by 98.81% to $52285.0 in 2026.
- Business Quant data shows LXEO's Shares Issued at $52285.0 in Q1 2026, $4.4 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - | 52,285.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,285.00 |
| Mar 31, 2026 | 52,285.00 |
| Dec 31, 2025 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 65,342.00 |
| Mar 31, 2025 | 65,342.00 |
| Dec 31, 2024 | 3.46 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Dec 31, 2023 | 2.42 Mn |